Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -1.10%
March 31, 2026 -1.00%
December 31, 2025 30.98%
September 30, 2025 -0.04%
June 30, 2025 5.02%
March 31, 2025 13.61%
December 31, 2024 20.84%
September 30, 2024 9.89%
June 30, 2024 8.64%
March 31, 2024 16.65%
December 31, 2023 18.71%
September 30, 2023 19.27%
June 30, 2023 27.20%
March 31, 2023 24.93%
December 31, 2022 34.26%
September 30, 2022 16.34%
June 30, 2022 17.94%
March 31, 2022 19.61%
December 31, 2021 27.84%
September 30, 2021 27.04%
June 30, 2021 18.54%
March 31, 2021 23.05%
December 31, 2020 26.02%
September 30, 2020 27.91%
June 30, 2020 17.74%
Date Value
March 31, 2020 27.87%
December 31, 2019 27.25%
September 30, 2019 30.64%
June 30, 2019 31.14%
March 31, 2019 30.48%
December 31, 2018 26.88%
September 30, 2018 34.70%
June 30, 2018 33.56%
March 31, 2018 22.65%
December 31, 2017 23.98%
September 30, 2017 33.43%
June 30, 2017 34.11%
March 31, 2017 37.31%
December 31, 2016 27.71%
September 30, 2016 45.14%
June 30, 2016 35.64%
March 31, 2016 33.27%
December 31, 2015 28.19%
September 30, 2015 29.16%
June 30, 2015 24.74%
March 31, 2015 28.02%
December 31, 2014 39.77%
September 30, 2014 22.94%
June 30, 2014 29.30%
March 31, 2014 21.88%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. 35.34%
Codexis, Inc. 68.42%
Lonza Group AG --
Quanterix Corp. 38.52%
Sartorius Stedim Biotech SA 46.86%

Gross Profit Margin (Quarterly) Related Metrics